We all know that smoking is bad for our health. But how bad is bad? The answer is very bad. It takes a decade off of life.
Death rates are about 3 times higher for smokers than nonsmokers. The chance that a young person will live to age 80 is about 70% for nonsmokers but about 35% for smokers. Stated differently, a smoker loses about 11(women) to 12 (men) years of life compared to no
nsmokers.
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
Now that women have been smoking for long periods of time, their risks match those of men who smoke. “Women who smoke like men die like men who smoke.” Women’s relative risk of developing and dying from lung cancer (compared to nonsmoking women) is about 25, same as for men. For chronic lung disease, the relative risks are 23 and 25 for women and men, respectively. For ischemic heart disease the relative risks are 2.9 and 2.5 and for stroke they are 2.1 and 1.9.
These are the results presented from two studies of very large populations of Americans published January 24, 2013 by the New England Journal of Medicine, one by Prabhat Jha and colleagues and another by Michael Thun and colleagues. Each analyzed different populations but arrived at essentially the same conclusions.
Alarming as these numbers appear, there is hope. Those who quit smoking will gain back substantial years of life, with more years gained the sooner one ceases smoking. For example, in Jha’s analysis, those who quit in the age range 25-34 reverted almost to the nonsmoker status – they gained back 10 years of life. Stopping between 35-44 years of age gained 9 years and between 45-54 years of age the gain was 6 years.
It is never too late to quit and the benefits are clearly substantial.
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
Stephen C Schimpff, MD is an internist, professor of medicine and public policy, former CEO of the University of Maryland Medical Center and is chair of the advisory committee for Sanovas, Inc. and senior advisor to Sage Growth Partners. He is the author of The Future of Medicine – Megatrends in Healthcare and The Future of Health Care Delivery- Why It Must Change and How It Will Affect You
Former academic hospital CEO, health system COO, professor of medicine and public policy, internist. Recent author of three books: The Future of Medicine - Megatrends in Healthcare; Alignment; and The Future of Health Care Delivery - Why It Must Change and How It Will Affect You.
Senior adviser to Sage Growth Partners
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.